| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| CHRM3 |
1-Azabicyclo[2.2.2]octan-2-yl(diphenyl)methanol;hydrobromide |
NA |
6599000 |
NA |
NA |
NA |
NA |
TTD |
| CHRM3 |
1-Azabicyclo[2.2.2]octan-4-yl(diphenyl)methanol;hydrobromide |
NA |
1068000 |
NA |
NA |
NA |
NA |
TTD |
| CHRM3 |
2-(1-Azabicyclo[2.2.2]octan-3-yl)-1,1-diphenylethanol;hydrobromide |
NA |
145000 |
NA |
NA |
NA |
NA |
TTD |
| CHRM3 |
Cefepime |
NA |
NA |
NA |
NA |
NA |
300000 |
PubChem |
| CHRM3 |
Ceftazidime |
NA |
NA |
NA |
NA |
NA |
300000 |
PubChem |
| CHRM3 |
Aztreonam |
NA |
NA |
NA |
NA |
NA |
400000 |
PubChem |
| CHRM3 |
Carbachol |
NA |
NA |
NA |
50118700000000 |
NA |
NA |
PubChem |
| CHRM3 |
Xanomeline |
NA |
NA |
NA |
39810700000000 |
NA |
NA |
PubChem |
| CHRM3 |
Carumonam |
NA |
NA |
NA |
NA |
NA |
500000 |
PubChem |
| CHRM3 |
(2S)-2-(5-methylfuran-2-yl)pyrrolidine |
147910.84 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| CHRM3 |
Doripenem |
NA |
NA |
NA |
NA |
NA |
300000 |
PubChem |
| CHRM3 |
3-(Hydroxydiphenylmethyl)-1-azoniabicyclo[2.2.2]octane bromide |
NA |
1104000 |
NA |
NA |
NA |
NA |
BindingDB |
| CHRM3 |
2-(Hydroxydiphenylmethyl)-1-azoniabicyclo[2.2.2]octane bromide |
NA |
6599000 |
NA |
NA |
NA |
NA |
BindingDB |
| CHRM3 |
2-(1-Azabicyclo[2.2.2]oct-3-yl)-1,1-diphenylethanol |
NA |
145000 |
NA |
NA |
NA |
NA |
BindingDB |
| CHRM4 |
1-Phenyl-2,3,4,9-tetrahydro-1H-beta-carboline |
300000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| CHRM4 |
1-(3-Methoxyphenyl)-2,3,4,9-tetrahydro-1H-beta-carboline |
300000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| CHRM4 |
2-fluoro-6-((2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)methyl)phenol |
300000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| CHRM4 |
4-[2-[(4-Hydroxy-4,4-diphenylbutyl)-methylamino]ethyl-methylamino]-1,1-diphenylbutan-1-ol;dihydrochloride |
162181.01 |
NA |
NA |
NA |
NA |
NA |
TTD |
| CHRM4 |
(2S)-2-(furan-2-yl)pyrrolidine |
102329.3 |
NA |
NA |
NA |
NA |
NA |
TTD |
| CHRM4 |
(2S)-2-(5-methylfuran-2-yl)pyrrolidine |
208929.61 |
NA |
NA |
NA |
NA |
NA |
TTD |